Patent: RE39916
✉ Email this page to a colleague
Summary for Patent: RE39916
| Title: | Compounds that modulate PPAR activity and methods for their preparation |
| Abstract: | This invention discloses compounds that alter PPAR activity. The invention also discloses pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable compositions comprising the compounds of their salts, and methods of using them as therapeutic agents for treating or preventing disipidemia, hypercholesteremia, obesity, eating disorders, hyperglycemia, atherosclerosis, hypertriglyceridemia, hyperinsulinemia and diabetes in a mammal as well as methods of suppressing appetite and modulating leptin levels in a mammal. The present invention also discloses methods for making the disclosed compounds. |
| Inventor(s): | Auerbach; Bruce J. (Ann Arbor, MI), Bratton; Larry D. (Whitmore Lake, MI), Filzen; Gary (Ann Arbor, MI), Geyer; Andrew G. (Novi, MI), Trivedi; Bharat K. (Farmington Hills, MI), Unangst; Paul C. (Ann Arbor, MI) |
| Assignee: | Warner Lambert Company (Morris Plains, NJ) |
| Application Number: | 11/288,022 |
| Patent Claims: | see list of patent claims |
Details for Patent RE39916
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Try a Trial | 2022-04-05 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
